Oxford Finance Provides $17 Million Debt Financing Facility to Entellus Medical

Oct 23, 2012, 10:00 ET from Oxford Finance LLC

ALEXANDRIA, Va., Oct. 23, 2012 /PRNewswire/ -- Oxford Finance LLC ("Oxford"), a specialty finance firm that provides senior debt to life sciences and healthcare services companies, today announced that it closed a $17 million senior secured term loan with Entellus Medical. Proceeds of the loan are being used to support the company's ongoing commercialization of its therapeutic solutions for healthcare providers and their patients who suffer from sinusitis.

"Oxford is very pleased to provide Entellus Medical capital to market its innovative technologies," said Christopher A. Herr, managing director for Oxford Finance. "Entellus Medical's high quality and minimally invasive therapeutic solutions greatly improve the procedure for treating sinusitis."

"These funds allow Entellus to expand its efforts to bring highly efficacious and cost-saving sinusitis treatments to patients who can be treated in the convenience of the doctor's office," said Brian Farley, president and chief executive officer of Entellus. "In doing so, doctors reduce the cost of treatment compared to conventional sinus surgery, while providing patients a treatment alternative with lower co-pays and very fast recovery."

About Oxford Finance LLC

Oxford Finance is a specialty finance firm providing senior secured loans to public and private life sciences and healthcare services companies worldwide. For over 20 years, Oxford has delivered flexible financing solutions to its clients, enabling these companies to maximize their equity by leveraging their assets. In recent years, Oxford has originated nearly $2 billion in loans, with lines of credit ranging from $500 thousand to $50 million. Oxford is headquartered in Alexandria, Virginia, with additional offices in California, Illinois, Massachusetts and North Carolina. For more information visit www.oxfordfinance.com.

About Entellus Medical

Entellus Medical provides complete solutions for the minimally invasive treatment of chronic and recurrent sinusitis patients and is leading the way with easy-to-use, cost-effective products for balloon dilation of narrowed sinus pathways. For information on the Entellus sinus dilation products, the XprESS™ Multi-Sinus Dilation Tool, FinESS™ Sinus Treatment, or PathAssist™ sinus confirmation tools visit www.entellusmedical.com.

SOURCE Oxford Finance LLC